News Releases


Oct 31, 2002

Insmed Incorporated To Webcast Third Quarter Earnings Conference Call; Thursday, October 31, 2002, at 8:30 a.m. ET -7:30 a.m. CT

Oct 30, 2002

Insmed Incorporated Reports Third Quarter Results

Oct 7, 2002

Insmed Acquires IGF-1 Regulatory Files for Growth Hormone Insensitivity Syndrome From Pharmacia; Extensive Regulatory Files Expected to Expedite Commercialization of SomatoKine

Sep 23, 2002

Insmed Restructures to Advance Most Promising Drug Candidates and Optimize Resources

Sep 10, 2002

Insmed Discontinues Internal Development of INS-1 for Diabetes and Polycystic Ovary Syndrome - PCOS -

Sep 9, 2002

Insmed Announces Appointment of Mary Callan as Vice President of Corporate Development

Aug 19, 2002

Insmed Announces Appointment of Vice President of Commercial Development

Jul 29, 2002

Insmed Incorporated and Avecia Limited Announce Development and Manufacturing Agreement for SomatoKine

Jul 26, 2002

Insmed Incorporated Reports Second Quarter Results

Jul 25, 2002

Insmed Incorporated Invites You to Join Its 2nd Quarter Earnings Conference Call On: Tuesday, July 30, 2002 at 9:00 a.m. EDT